Ultrasonographic screening for fetal chromosomal abnormalities in early pregnancy

References

• Pandya PP, Snijders RJM, Pasara N, Hilbert L, Nicolaides KH. The prevalence of non-viable pregnancy at 10–13 weeks of gestation. Ultrasound Obstet Gynecol 1996; 7: 170–3.
   PubMed Web of Science ®Google Scholar
• Sepulveda W, Sebire NJ, Hughes K, Odibo A, Nicolaides KH. The lambda sign at 10–14 weeks of gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet Gynecol 1996; 7: 421–3.
   Google Scholar
• Rottem S, Bronshtein M, Thaler I, Brandes J. First trimester transvaginal sonographic diagnosis of fetal anomalies. Lancet 1989; 1: 444–5.
   PubMed Web of Science ®Google Scholar
• Rottem S, Bronshtein M. Transvaginal sonographic diagnosis of congenital anomalies between 9 weeks and 16 weeks, menstrual age. J Clin Ultrasound 1990; 18: 307–14.
   Google Scholar
• Benacerraf BR, Gelman R, Frigoletto FD. Sonographic detection of 2nd trimester fetuses with Down syndrome. New Engl J Med 1987; 317: 1371–6.
   Google Scholar
• Benacerraf BR, Miller WA, Frigoletto FD. Sonographic detection of fetuses with trisomies 13 and 18: accuracy and limitations. Am J Obstet Gynecol 1988; 158: 404–9.
   Google Scholar
• Nyberg DA, Resta RG, Luthy DA, Hickok DE, Mahony DS, Hirsch JH. Prenatal sonographic findings of Down syndrome: review of 94 cases. Obstet Gynecol 1990; 76: 370–7.
   PubMed Web of Science ®Google Scholar
• Benacerraf BR, Laboda LA, Frigoletto FD. Thickened nuchal fold in fetuses not at risk for aneuploidy. Radiology 1992; 184: 239–42.
   Google Scholar
• Chitty LS, Hunt GH, Moore J, Lobb MO. Effectiveness of routine ultrasonography in detecting fetal structural abnormalities in a low risk population. Br J Med 1991; 303: 1165–9.
   PubMed Web of Science ®Google Scholar
• Levi S, Hyjazi Y, Schaaps J-P, Defoort P, Coulon R, Buek- ens P Sensitivity and specificity of routine antenatal screening for congenital screening for congenital anomalies by ultrasound: The Belgian multicentric study. Ultrasound Obstet Gynecol 1991; 1: 102–10.
   Google Scholar
• Rosendahl H, Kivinen S. Antenatal detection of congenital malformations by routine ultrasonography. Obstet Gynecol 1989; 73: 947–51.
   PubMed Web of Science ®Google Scholar
• Saari-Kemppainen A, Karjalainen O, Ylöstalo P, Heinonen OP. Fetal anomalies in a controlled one-stage ultrasound screening trial. A report from the Helsinki Ultrasound Trial. J Perinat Med 1994; 22: 279–89.
   Google Scholar
• Shirley IM, Bottomley F, Robinson VP Routine radiographer screening for fetal abnormalities by ultrasound in an unselected low risk population. Br J Radiol 1992; 65: 565–9.
   Google Scholar
• Hyett J, Noble PL, Snijders RJM, Montenegro N, Nicolaides KH. Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10–14 weeks of gestation. Ultrasound Obstet Gynecol 1996; 7: 239–44.
   Google Scholar
• Jauniaux E, Garvrill P, Khun P, Kurdi W, Hyett J, Nicolaides KH. Fetal heart rate and umbilico-placental Doppler flow velocity waveforms in early pregnancies with a chromosomal abnormality and/or increased nuchal trans- lucency thickness. Hum Reprod 1996; 11: 435–9.
   Google Scholar
• Martinez JM, Comas C, Ojuel J, Borrell A, Puerto B, Fortuny A. Fetal heart rate patterns in pregnancies with chromosomal disorders of subsequent fetal loss. Obstet Gynecol 1996; 87: 118–21.
   PubMedGoogle Scholar
• Lynch L, Berkowitz RL. First trimester growth delay in trisomy 18. Am J Perinatol 1989; 6: 237–9.
   Google Scholar
• Kuhn P, Brizot de Lourdes M, Pandya PP, Snijders RJ, Nicolaides KH. Crown-rump length in chromosomally abnormal fetuses at 10 to 13 weeks’ gestation. Am J Obstet Gynecol 1995; 172: 32–5.
   PubMed Web of Science ®Google Scholar
• Leelapatana P, Garrett WJ, Warren PS. Early growth retardation in the first trimester: is it characteristic of the chromosomally abnormal fetus? Aust NZ Obstet Gynaecol 1992; 32: 95–7.
   Google Scholar
• Snijders RJM, Sebire NJ, Souka A, Santiago C, Nicolaides KH. Fetal exomphalos and chromosomal defects: relationship to maternal age and gestation. Ultrasound Obstet Gynecol 1995; 6: 250–5.
   Google Scholar
• Ville Y, Lalondrelle C, Doumerc S. First-trimester diagnosis of nuchal anomalies: significance and fetal outcome. Ultrasound Obstet Gynecol 1992; 2: 314–16.
   Google Scholar
• Pandya PP, Snijders RJM, Johnson SJ, Brizot M, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995; 102: 957–62.
   Google Scholar
• Snijders RJ, Johnson S, Sebire NJ, Noble PL, Nicolaides KH. First trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol 1996; 7: 216–26.
   PubMed Web of Science ®Google Scholar
• Taipale P, Hiilesmaa V Salonen R, Ylöstalo P Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med 1997; 337: 1654–8.
   PubMed Web of Science ®Google Scholar
• Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343–6.
   Google Scholar
• Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867–9.
   Google Scholar
• Szabo J, Gellen J. Nuchal fluid accumulation in trisomy 21 detected by vaginography in first trimester. Lancet 1990; 336: 1133.
   PubMed Web of Science ®Google Scholar
• Cullen MT, Gabrielli S, Green J. Diagnosis and significance of cystic hygroma in the first trimester. Prenat Diagn 1990; 10: 643–51.
   Google Scholar
• Schulte-Vallentin M, Schindler H. Non-echogenic nuchal oedema as a marker in trisomy 21 screening. Lancet 1992; 339: 1053.
   Google Scholar
• Pandya PP, Brizot ML, Kuhn P, Snijders RJM, Nicolaides KH. First-trimester fetal nuchal translucency thickness and risk for trisomies. Obstet Gynecol 1994; 84: 420–3.
   Google Scholar
• Comas C, Martinez JM, Ojuel J, Casals E, Puerto B, Borrell A et al. First-trimester nuchal edema as a marker of aneuploidy. Ultrasound Obstet Gynecol 1995; 5: 26–9.
   PubMedGoogle Scholar
• Braithwaite JM, Morris RW, Economides DL. Nuchal translucency measurements: frequency distribution and changes with gestation in a general population. Br J Obstet Gynaecol 1996; 103: 1201–4.
   Google Scholar
• Szabo J, Gellen J, Szemere G. First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age. Ultrasound Obstet Gynecol 1995; 5: 161–3.
   Google Scholar
• Bewley S, Roberts LJ, Mackinson AM, Rodeck CH. First trimester fetal nuchal translucency: problems with screening the general population. 2. Br J Obstet Gynaecol 1995; 102: 386–8.
   Google Scholar
• Savoldelli G, Binkert F, Achermann J, Schmid W. Ultrasound screening for chromosomal anomalies in the first trimester of pregnancy. Prenat Diagn 1993; 13: 513–18.
   PubMedGoogle Scholar
• Nicolaides KH, Brizot ML, Snijders RJM. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol 1994; 101: 782–6.
   Google Scholar
• Brambati B, Cislaghi C, Tului L, Alberti E, Amidani M, Colombo U et al. First-trimester Down’s syndrome screening using nuchal translucency: a prospective study in patients undergoing chorionic villus sampling. Ultrasound Obstet Gynecol 1995; 5: 9–14.
   PubMed Web of Science ®Google Scholar
• Borrell A, Costa D, Martinez JM, Delgado RD, Farguell T, Fortuny A. Criteria for fetal nuchal thickness cut-off: a re-evaluation. Prenat Diagn 1997; 17: 23–9.
   PubMed Web of Science ®Google Scholar
• Braithwaite JM, Economides DL. The measurement of nuchal translucency with transabdominal and transvaginal sonography – success rates, repeatability and levels of agreement. Br J Radiol 1995; 68: 720–3.
   Google Scholar
• Hafner E, Schuchter K, Philipp K. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency. Ultrasound Obstet Gynecol 1995; 6: 330–3.
   Web of Science ®Google Scholar
• Hafner E, Schuchter K, Leibhart E, Philipp K. Results of routine fetal nuchal translucency measurements at 10–13 weeks in 4233 unselected pregnant women. Prenat Diagn 1998; 18: 29–34.
   PubMed Web of Science ®Google Scholar
• Economides DL, Whitlow BJ, Kadir R, Lazanakis M, Verdin SM. First trimester sonographic detection of chromosomal abnormalities in an unselected population. Br J Obstet Gynaecol 1998; 105: 58–62.
   Google Scholar
• Jones DC. Nonimmune fetal hydrops: diagnosis and obstetrical management. Semin Perinat 1995; 6: 447–61.
   Google Scholar
• Singh RP, Carr DH. The anatomy and histology of XO embryos and fetuses. Anat Rec 1966; 155: 369–84.
   PubMedGoogle Scholar
• Stephens TD, Shepard TH. Down syndrome in the fetus. Teratology 1980; 22: 37–41.
   Google Scholar
• Chervenak FA, Isaacson G, Blakemore K, Breg WR, Hob- bins JC, Berkowitz RL et al. Fetal cystic hygroma: cause and natural history. N Engl J Med 1983; 309: 822–5.
   PubMed Web of Science ®Google Scholar
• Benacerraf BR, Frigoletto FD Jr. Prenatal sonographic diagnosis of isolated congenital cystic hygroma, unassociated with lymphedema or other morphologic abnormality. J Ultrasound Med 1987; 6: 63–6.
   PubMed Web of Science ®Google Scholar
• Wilson RD, Venir N, Farquharson DF. Fetal nuchal fluid – physiological or pathological – in pregnancies less than 17 menstrual weeks. Prenat Diagn 1992; 12: 755–63.
   Google Scholar
• Nadel A, Bromley B, Benacerraf BR. Nuchal thickening or cystic hygromas in first- and early second-trimester fetuses: prognosis and outcome. Am J Obstet Gynecol 1993; 82: 43–7.
   Google Scholar
• Greco P, Loverro G, Vimercati A, Marzullo A, Caruso G, Selvaggi L. Pathological significance of first-trimester fetal nuchal oedema. Prenat Diagn 1996; 16: 503–9.
   Google Scholar
• Hohlfeld P, Mac-Aleese J, Capella-Pavlovski M. Fetal toxoplasmosis: ultrasonographic signs. Ultrasound Obstet Gynecol 1991; 1: 241–4.
   PubMed Web of Science ®Google Scholar
• Mazeron M-C, Cordovi-Voulgaropoulos C, Perol Y. Transient hydrops fetalis associated with intrauterine cytomegalovirus infection. Obstet Gynecol 1994; 84: 692–4.
   Google Scholar
• Barron SD, Pass RF. Infectious causes of hydrops fetalis. Semin Perinatol 1995; 19: 493–501.
   PubMed Web of Science ®Google Scholar
• Jordan JA. Identification of human parvovirus B 19 in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol 1996; 174: 37–42.
   Google Scholar
• Sebire NJ, Bianco D, Snijders RJM, Zuckermann M, Nicolaides KH. Increased nuchal translucency thickness at 10–14 weeks: is screening for maternal-fetal infection necessary? Br J Obstet Gynaecol 1997; 104: 212–15.
   Google Scholar
• Moscoso G. Fetal nuchal translucency: a need to understand the physiological basis. Ultrasound Obstet Gynecol 1995; 5: 6–8.
   PubMedGoogle Scholar
• Chodirker BN, Harman CR, Greenberg CR. Spontaneous resolution of a cystic hygroma in a fetus with Turner syndrome. Prenat Diagn 1988; 8: 291–6.
   Google Scholar
• Rodis JF, Vintzileos AM, Campbell WA, Nochimson DJ. Spontaneous resolution of fetal cystic hygroma in Down’s syndrome. Obstet Gynecol 1988; 71: 976–7.
   Google Scholar
• Hyett J, Moscoso G, Papapana G, Perdu M, Nicolaides KH. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal trans- lucency thickness at 11–13 weeks of gestation. Ultrasound Obstet Gynecol 1996; 7: 245–50.
   Google Scholar
• Souka AP, Snijders RJM, Novakos A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10–4 weeks of gestation. Ultrasound Obstet Gynecol 1998; 11: 391–400.
   Google Scholar
• Nicolaides KH, Azar G, Snijders RJ, Gosden CM. Fetal nuchal oedema: associated malformations and chromosomal defects. Fetal Diagn Ther 1992; 7: 123–31.
   Google Scholar
• Ämmäla P, Salonen R. First-trimester diagnosis of hydro- lethalus syndrome. Ultrasound Obstet Gynecol 1995; 5: 60–2.
   Google Scholar
• Jauniaux E, Van Maldergem L, De Munter C, Moscoso G, Gillerot Y. Non-immune hydrops fetalis associated with genetic abnormalities. Obstet Gynecol 1990; 75: 568–72.
   PubMed Web of Science ®Google Scholar
• Zarabi M, Mieckowski GC, Mazer J. Cystic hygroma associated with Noonan’s syndrome. J Ultrasound 1983; 11: 398–400.
   Google Scholar
• Benacerraf BR, Greene MF, Holmes L. The prenatal sonographic features of Noonan’s syndrome. J Ultrasound Med 1989; 8: 59–63.
   Google Scholar
• Graham JD, Stephens TD, Shepard TH. Nuchal cystic hygroma in a fetus with presumed Roberts syndrome. Am J Med Genet 1983; 15: 163–7.
   Google Scholar
• Taipale P Transvaginal ultrasonic screening of a non-selected population for fetal aneuploidy, placenta previa and premature delivery. Academic Dissertation. University of Helsinki, Helsinki, Finland, 1998.
   Google Scholar
• Snijders RJM, Holzgreve W, Cuckle H, Nicolaides KH. Maternal age-specific risk for trisomies at 9–14 weeks’ gestation. Prenat Diagn 1994; 14: 543–52.
   Google Scholar
• Pandya PP, Kondylios A, Hilbert L, Snijders RJM, Nicolaides KH. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 1995; 5: 15–19.
   Google Scholar
• Roberts LJ, Bewley S, Mackinson AM, Rodeck CH. Fetal nuchal translucency: problems with screening the general population 1. Br J Obstet Gynaecol 1995; 102: 381–5.
   Google Scholar
• Kornman LH, Morssink LP, Beekhuis JR, De Wolf BTHM, Heringa MP, Mantingh A. Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester in a routine ultrasound practice. Prenat Diagn 1996; 16: 797–805.
   Google Scholar
• Haddow JE, Palomaki GE, Knight GE, Williams J, Millier WA, Johnson A. Screening of maternal serum for fetal Down’s syndrome in the first trimester. N Engl J Med 1998; 338: 955–61.
   PubMed Web of Science ®Google Scholar
• Whitlow BJ, Chatzipapas IK, Economides DL. The effect of fetal neck position on nuchal translucency measurement. Br J Obstet Gynaecol 1998; 105: 872–6.
   Google Scholar
• Pandya PP, Altman DG, Brizot ML, Pettersen H, Nicolaid- es KH. Repeatability of fetal nuchal translucency thickness. Ultrasound Obstet Gynecol 1995; 5: 334–7.
   PubMedGoogle Scholar
• Braithwaite JM, Kadir RA, Pepera T, Morris R, Thompson P, Economides DL. Nuchal translucency measurement: training of potential examiners. Ultrasound Obstet Gynecol 1996; 8: 192–6.
   PubMed Web of Science ®Google Scholar
• Grudzinskas JG, Ward RHT. Screening for Down’s syndrome in the first trimester. London: RCOG Press, 1997: 354.
   Google Scholar
• Macintosh MCM, Wald NJ, Chard T, Hansen J, Mikkelsen M, Therkelsen JA et al. Selective miscarriage of Down’s syndrome fetuses in women aged 35 years and older. Br J Obstet Gynaecol 1995; 102: 798–801.
   PubMedGoogle Scholar
• Pandya PP, Snijders RJM, Johnson S, Nicolaides KH. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 1995; 5: 381–3.
   Google Scholar
• Bronshtein M, Blumenfeld Z. Transvaginal sonography – detection of findings suggestive of fetal chromosomal anomalies in the first and early second trimester. Prenat Diagn 1992; 12: 587–93.
   Google Scholar
• Hyett JA, Moscoso G, Nicolaides KH. First-trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21. Am J Obstet Gynecol 1995; 172: 1411–13.
   Google Scholar
• Sebire NJ, von Kaisenberg C, Rubio C, Snijders RJM, Nicolaides KH. Fetal megacystis at 10–14 weeks of gestation. Ultrasound Obstet Gynecol 1996; 8: 387–90.
   Google Scholar
• Economides DL, Braithwaite JM. First trimester ultrasonographic diagnosis of fetal structural abnormalities in a low risk population. Br J Obstet Gynaecol 1998; 105: 53–7.
   PubMedGoogle Scholar
• Blaas H-G. National Center for Fetal Medicine. Trondheim, Norway. Personal information, 1998.
   Google Scholar
• Grimes PA, Cates W Complications from legally induced abortion: a review. Obstet Gynecol Surv 1979; 34: 177–91.
   PubMedGoogle Scholar
• Konyne LM, Smith JC, Ramick M, Lawson HW Abortion surveillance – United States, 1989. Morb Mortal Wkly Rep 1993; 41: 1–33.
   Google Scholar
• White-van Mourik M, Connor J, Ferguson-Smith M. The psychological sequelae of a second trimester termination of pregnancy for a fetal abnormality. Prenat Diagn 1992; 12: 189–204.
   Google Scholar
• Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulk- kinen A, Canick JA et al. Prenatal screening for Down’s syndrome with use of maternal serum markers. N Engl J Med 1992; 327: 588–93.
   PubMed Web of Science ®Google Scholar
• Biagotti R, Brizzi L, Periti E, d’Agata A, Vanzi E, Cariati E. First trimester screening for Down’s syndrome using maternal serum PAPP-A and free ß-hCG in combination with fetal nuchal translucency thickness. Br J Obstet Gynaecol 1998; 105: 917–20.
   Google Scholar